RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jerrold Levy, MD

Anesthesiology · Durham, NCNPI 1891863429

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (39.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by CSL Behring at 24.8% of the total. Among anesthesiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$305,017in general payments, 2019–2025

Across 230 payments — averaging $1326.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$76K
  • Instrumentation Laboratory Company$59K
  • Octapharma USA, Inc.$42K
  • Grifols Shared Services North America, Inc.$26K
  • Bayer$16K
  • Merck$16K
  • plus $71K from 18 others
$13,579in research payments, 2019–2025

Across 8 payments — averaging $1697.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Octapharma USA, Inc.$9K
  • Takeda Pharmaceuticals U.S.A., Inc.$4K

What the payments were for

  • Consulting fees$120,99940%
  • Speaking & faculty fees$87,38529%
  • Travel & lodging$91,44330%
  • Food & beverage$5,1912%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring55$75,556
Instrumentation Laboratory Company38$58,690
Octapharma USA, Inc.48$41,670
Grifols Shared Services North America, Inc.23$26,428
Bayer1$16,285
Merck12$15,540
Grifols, S.A.6$15,514
Boehringer Ingelheim (china) Investment Co., Ltd.8$15,259
Janssen Research & Development, LLC10$11,588
Daiichi Sankyo Inc.6$8,100
Takeda Pharmaceuticals U.S.A., Inc.2$6,197
Boehringer Ingelheim International GmbH2$4,652
Biotest AG1$4,000
Portola Pharmaceuticals, LLC4$2,186
Edwards Lifesciences3$1,150
BD2$750
Carestream Health, Inc.1$458
Cerus Corporation2$359
Werfen USA LLC1$289
Hemosonics LLC1$120
AstraZeneca1$86
Accriva Diagnostics Inc.1$62
Chiesi USA, Inc.1$44
Sanofi1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$305,017 in reported general payments places this provider in the 95th percentile of 1,149 anesthesiology providers in North Carolina.

See all anesthesiology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$36,752
Medicare patients
59
Services billed
191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Durham

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →